The latest closing stock price for Ovid Therapeutics as of November 20, 2024 is 1.04.
An investor who bought $1,000 worth of Ovid Therapeutics stock at the IPO in 2017 would have $-915 today, roughly -1 times their original investment - a -26.53% compound annual growth rate over 8 years.
The all-time high Ovid Therapeutics stock closing price was 15.00 on May 19, 2017.
The Ovid Therapeutics 52-week high stock price is 4.10, which is 294.2% above the current share price.
The Ovid Therapeutics 52-week low stock price is 0.68, which is 34.6% below the current share price.
The average Ovid Therapeutics stock price for the last 52 weeks is 2.29.
An investor who bought $1,000 worth of Ovid Therapeutics stock at the IPO in 2017 would have $-915 today, roughly -1 times their original investment - a -26.53% compound annual growth rate over 8 years.
The all-time high Ovid Therapeutics stock closing price was 15.00 on May 19, 2017.
The Ovid Therapeutics 52-week high stock price is 4.10, which is 294.2% above the current share price.
The Ovid Therapeutics 52-week low stock price is 0.68, which is 34.6% below the current share price.
The average Ovid Therapeutics stock price for the last 52 weeks is 2.29.